Make an enquiry
Refer a patient
Patient Portal
HCP Logout

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Find a centre
Find a doctor
Make an enquiry
Refer a patient

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Find a centre
Find a doctor
2024-06-14T12:24:04.603Z

GS-US-587-6156

GS-US-587-6156
Colorectal cancer

A Phase 2, Randomized, Open-Label Study of Magrolimab Given Together With FOLFIRI/ BEV in Patients with Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC) (ELEVATE CRC)

A Phase 2, Randomized, Open-Label Study of Magrolimab Given Together With FOLFIRI/ BEV in Patients with Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC) (ELEVATE CRC)

Trial overview

Clinical Area

Medical Oncology

Disease Site

Colorectal Cancer

Study Phase

II

Trial registration

Number: NCT05330429

https://clinicaltrials.gov/study/NCT05330429

GenesisCare Location(s)

GenesisCare North Shore 

 

GenesisCare North Shore    :::
Principal Investigator(s)

Dr David Chan

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.